Donal Landers

Dukes Street Bio Ltd
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR.

International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 23, 2026

Translating the machine; An assessment of clinician understanding of ophthalmological artificial intelligence outputs.

Translating the machine; An assessment of clinician understanding of ophthalmological artificial intelligence outputs.

Journal: International journal of medical informatics

Published: March 27, 2025

Assessing the communication gap between AI models and healthcare professionals: Explainability, utility and trust in AI-driven clinical decision-making.

Assessing the communication gap between AI models and healthcare professionals: Explainability, utility and trust in AI-driven clinical decision-making.

Journal: Artificial intelligence

Published: March 01, 2023

Digital ECMT Cancer Trial Matching Tool: an Open Source Research Application to Support Oncologists in the Identification of Precision Medicine Clinical Trials.

Digital ECMT Cancer Trial Matching Tool: an Open Source Research Application to Support Oncologists in the Identification of Precision Medicine Clinical Trials.

Journal: JCO clinical cancer informatics

Published: January 19, 2023

Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer.

Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer.

Journal: Nature communications

Published: January 17, 2023

Meta-analysis informed machine learning: Supporting cytokine storm detection during CAR-T cell Therapy.

Meta-analysis informed machine learning: Supporting cytokine storm detection during CAR-T cell Therapy.

Journal: Journal of biomedical informatics

Published: December 23, 2022

A systematic review of biologically-informed deep learning models for cancer: fundamental trends for encoding and interpreting oncology data.

A systematic review of biologically-informed deep learning models for cancer: fundamental trends for encoding and interpreting oncology data.

Journal: BMC bioinformatics

Published: August 17, 2022

An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves.

An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves.

Journal: Cancers

Published: June 12, 2022

Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital.

Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital.

Journal: JCO clinical cancer informatics

Published: May 24, 2022

Biomarker identification using dynamic time warping analysis: a longitudinal cohort study of patients with COVID-19 in a UK tertiary hospital.

Biomarker identification using dynamic time warping analysis: a longitudinal cohort study of patients with COVID-19 in a UK tertiary hospital.

Journal: BMJ open

Published: February 16, 2022

Patient attrition in Molecular Tumour Boards: a systematic review.

Patient attrition in Molecular Tumour Boards: a systematic review.

Journal: British journal of cancer

Published: January 05, 2022

Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer.

Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer.

Journal: Nature communications

Published: September 21, 2021

Showing 1-12 of 23

Last Updated: 09/26/2026